New study tracks immune therapy results in advanced liver cancer
Knowledge-focused
Not yet recruiting
This study will follow 75 adults with advanced liver cancer who are already receiving immune checkpoint inhibitors as part of their regular care. Researchers will track how long patients live and how long the cancer stays under control. The goal is to better understand the real-w…
Sponsor: Ahmed Karam Helmy • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:08 UTC